Prediabetes and Diabetes Prevention: Screening, Atypical Cases, and Management with Dr. Scott Isaacs

Screening for Prediabetes and Diabetes

• 🎯 Over 38% of US adults have prediabetes, and many are unaware, highlighting the importance of screening.
• 🩺 Guidelines recommend screening adults aged 35-70 who are overweight or have obesity (USPSTF), or all adults over 35 (ADA), with earlier screening for younger individuals with risk factors.
• 🧪 Recommended screening tests include fasting plasma glucose, A1C, and 2-hour plasma glucose during an oral glucose tolerance test (OGTT).
• 📊 While A1C is a strong predictor, the OGTT (impaired glucose tolerance) is a stronger predictor of type 2 diabetes and cardiovascular complications, though less commonly used.

Identifying Atypical Prediabetes Cases

• ⚠️ It's crucial to consider atypical forms of prediabetes beyond insulin resistance.
• 💡 Latent autoimmune diabetes in adults (LADA), or pre-type 1 diabetes, should be suspected in younger individuals, those with lower body weight, or a family history of type 1 diabetes, often indicated by autoimmune markers.
• 🫀 Pancreatic prediabetes, associated with pancreatitis or exocrine insufficiency, and endocrine causes like Cushing syndrome and acromegaly, also require consideration.
• 🩺 Screening for these atypical cases may involve diabetes antibodies (like GAD65), insulin/C-peptide levels, and specific tests for endocrine disorders.

Managing Prediabetes: Lifestyle and Medications

• 🌱 Lifestyle changes, including a 7% weight loss, can reduce diabetes progression by 58%, as shown in the Diabetes Prevention Program study.
• 💊 Metformin is a first-line medication, reducing diabetes risk by about 30% and offering modest weight loss, typically titrated to 2 grams daily.
• 🚀 GLP-1 receptor agonists are highly effective, reducing diabetes risk by 75-95%, primarily through weight loss but also by improving glucose control.
• ✨ Pyoglitazone is highlighted for its ability to directly lower insulin resistance, reduce cardiovascular risk, and improve liver fat, with minimal weight gain when combined with other agents.

Comprehensive Approach to Prediabetes

• 🩺 A complication-centric approach is vital, focusing on reducing cardiovascular risk, preventing progression of metabolic dysfunction-associated steatotic liver disease (MASLD), and improving overall quality of life, rather than solely on glucose levels.
• 📈 Regular monitoring of A1C at least annually, or more frequently, is recommended for patients with prediabetes to track progress and maintain motivation.
• 🤝 Understanding patient preferences (minimalist vs. maximalist) is key to tailoring management strategies, whether focusing on lifestyle, medications, or a combination.